Valiant Laboratories (NSE:VALIANTLAB) Net Issuance of Debt : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Valiant Laboratories Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Valiant Laboratories's net issuance of debt for the three months ended in Mar. 2025 was ₹0 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.

Valiant Laboratories Net Issuance of Debt Historical Data

The historical data trend for Valiant Laboratories's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valiant Laboratories Net Issuance of Debt Chart

Valiant Laboratories Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Mar25

Net Issuance of Debt

132.14

-420.72

-12.81

166.50

451.54

Valiant Laboratories Quarterly Data
	Mar21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Issuance of Debt	Get a 7-Day Free Trial								-	-	-	-	-

Valiant Laboratories Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Valiant Laboratories Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Valiant Laboratories's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Valiant Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valiant Laboratories Ltd (NSE:VALIANTLAB) » Definitions » Net Issuance of Debt

Traded in Other Exchanges

543998:India

Address

Mulund Goregaon Link Road, 104, Udyog Kshetra, Mulund, MH, IND, 400080

Website

https://www.valiantlabs.in

Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.

Valiant Laboratories Headlines

No Headlines